INVOINVO Bioscience, Inc.

Nasdaq invobio.com


$ 0.76 $ -0.02 (-2.87 %)    

Wednesday, 28-Aug-2024 15:35:32 EDT
QQQ $ 468.16 $ -5.41 (-1.13 %)
DIA $ 411.36 $ -1.55 (-0.38 %)
SPY $ 558.32 $ -3.26 (-0.58 %)
TLT $ 97.88 $ -0.12 (-0.12 %)
GLD $ 231.76 $ -1.64 (-0.7 %)
$ 0.7813
$ 0.76
$ 0.82 x 100
-- x --
$ 0.76 - $ 0.76
$ 0.50 - $ 3.50
46,177
na
3.05M
$ 3.14
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 04-16-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 04-17-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 03-30-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
17 08-13-2020 06-30-2020 10-Q
18 05-15-2020 03-31-2020 10-Q
19 03-30-2020 12-31-2019 10-K
20 11-14-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 04-16-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 03-29-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 09-05-2017 03-31-2016 10-Q
30 09-05-2017 06-30-2016 10-Q
31 09-05-2017 09-30-2016 10-Q
32 08-10-2017 06-30-2017 10-Q
33 05-15-2017 03-31-2017 10-Q
34 04-20-2017 12-31-2016 10-K
35 03-17-2017 12-31-2015 10-K
36 11-21-2011 09-30-2011 10-Q
37 08-22-2011 06-30-2011 10-Q
38 05-23-2011 03-31-2011 10-Q
39 04-15-2011 12-31-2010 10-K
40 11-22-2010 09-30-2010 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 invo-bioscience-says-on-june-18-2024-co-received-notice-from-nasdaq-informing-co-was-granted-request-for-continued-listing-on-nasdaq

-SEC Filing 

 invo-bioscience-q1-eps-042-sales-158m-up-from-34802k-yoy

INVO Bioscience (NASDAQ:INVO) reported quarterly losses of $(0.42) per share. The company reported $1.58 million in sales this ...

 crude-oil-dips-3-us-bancorp-profit-tops-views

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The D...

 why-travelers-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

 nasdaq-down-over-1-sage-therapeutics-shares-plunge

U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow trad...

 why-invo-bioscience-stock-is-soaring-today

Invo Bioscience reported $1.38 million in quarterly sales, representing a 396.15% increase over sales of $278,140 from the same...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION